Digest Network How does it work
Network
/
Society
Ha
Not verified

Hansa Biopharma AB

What we write about

BiologyEconomicsImpresePharmaceuticalsSanità

23 Press releases

View all press releases
29/07/2025
Health
Fitness / Wellness
Medicine - various
Hansa Biopharma announces key executive appointments to support continued growth
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
17/07/2025
Health
Fitness / Wellness
Economics
Medicine - various
Environmental health
Agriculture
Hansa Biopharma Reports Second Quarter and Interim January-June 2025 Financial Results
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
08/07/2025
Health
Fitness / Wellness
Medicine - various
Environmental health
Agriculture
Hansa Biopharma appoints Dr Richard Philipson as Chief Medical Officer
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
11/06/2025
Health
Fitness / Wellness
Fairs
Eventi
Medicine - various
Environmental health
Agriculture
Hansa Biopharma to attend BIO International Convention
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
09/06/2025
Pharmaceuticals
Sanità
Media
Communication
Multimedia
Electronic publishing
Biology
Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
14/05/2025
Pharmaceuticals
Bank
Sanità
Economics
Start-up
Finance
Biology
Hansa Biopharma data at the 2025 PNS Annual Meeting demonstrates potential of imlifidase in the treatment of GBS
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
13/05/2025
Pharmaceuticals
Sanità
Economics
Management
Organizzazione Aziendale
Biology
Hansa Biopharma appoints Maria Törnsén as Chief Operating Officer and President U.S.
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
24/04/2025
Pharmaceuticals
Sanità
Imprese
Biology
Hansa Biopharma Reports First Quarter and Interim January-March 2025 Financial Results
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
21/03/2025
Pharmaceuticals
Sanità
Economics
Biology
Hansa Biopharma publishes 2024 Annual and Sustainability Reports
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
11/03/2025
Pharmaceuticals
Sanità
Hansa Biopharma completes enrolment in European Phase 3 20-HMedIdeS-19 Post Authorization Efficacy and Safety study in highly sensitized kidney transplant patients
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0